Nasus Pharma (NSRX) Stock: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.56
-0.03 (-0.70%)
▼
5d:
-0.15%
30d:
-13.06%
90d:
+1.85%
HOLD
LOW Confidence
Analysis Updated: Sep 29, 2026 12:00 AM ET
Earnings: Jun 24, 2026
0d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NSRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NSRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.56, which is considered slightly low relative to its 30-day fair value range of $3.47 to $3.96.
Technical Outlook: Technically, NSRX is in a strong uptrend. Immediate support is located at $3.35, while resistance sits at $3.79.
Market Sentiment: NSRX scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.67 (+447.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NSRX is in a strong uptrend. Immediate support is located at $3.35, while resistance sits at $3.79.
Market Sentiment: NSRX scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.67 (+447.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.47 -
$3.96
Company Quality Score
70/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (84/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 447.8% below Wall St target ($19.67)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.47 -
$3.96
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.35
Resistance Level
$3.79
Current Trend
Strong Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.19
Wall Street Target
$19.67
(+447.8%)
Share & Embed Analysis
Last updated: September 29, 2026 11:31 AM ET
Data refreshes hourly during market hours. Next update: 12:31 PM
Data refreshes hourly during market hours. Next update: 12:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1325 | 53 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$159 | 45 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$154 | 62 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$279 | 53 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$389 | 50 HOLD |